Amedisys’ High-Acuity, Non-Medicare Revenue Skyrockets As It Waits For UnitedHealth Group Deal To Close

Amedisys Inc. (Nasdaq: AMED) is waiting for multiple big-time transactions to come to fruition by year end. In the meantime, it continues to grow its non-Medicare revenue and its high-acuity care business considerably. The company released its second-quarter earnings on Wednesday, without an accompanying call. It has not held an official earnings call since UnitedHealth […]

Amedisys Continues To Drive Growth In Home Health, High-Acuity Care Segments

While waiting for UnitedHealth Group’s (NYSE: UNH) purchase of it to finalize, Amedisys Inc. (Nasdaq: AMED) continues to grow its home health segment – primarily through non-Medicare revenue – and its higher-acuity care segment. The company reported its first-quarter earnings late Wednesday, which showed a 10% increase in total same store admissions in home health […]

Exploring What An Amedisys Divestment Strategy Could Look Like

UnitedHealth Group (NYSE: UNH) and Amedisys Inc. (Nasdaq: AMED) announced combination plans last June, under which home health giant Amedisys would become part of Optum. Amedisys had previously entered into an agreement to merge with infusion therapy company Option Care Health (Nasdaq: OPCH), but UnitedHealth Group’s offer, scale and complementary clinical capabilities were effectively too […]

Deal Or No Deal: The Futures Of 3 Home-Based Care Companies

Most buyers in home health and personal care are signaling they’ll be more active in the M&A market this year. That’s according to a new Mertz Taggart report, which included responses from over 50 potential home-based care buyers. Nearly 80% said they planned to be more acquisitive in 2024 compared to 2023. But some of […]

What The UnitedHealth Group Antitrust Investigation Means For Amedisys, Home Health Industry

Since the news surfaced Tuesday that the Department of Justice had opened an antitrust investigation into UnitedHealth Group (NYSE: UNH), additional questions have bubbled up. Namely, those questions surround the home health provider Amedisys Inc. (Nasdaq: AMED), which agreed to be acquired by UnitedHealth Group’s Optum in June of last year. Will that deal be […]

Top Home Health Trends For 2024

In 2023, the decreasing influence of COVID-19 did not mitigate the overall operating pressures home health providers were forced to face. In the new year, there still remains plenty of opportunity, but much to work through to tap into that opportunity. More proposed rate cuts to home health reimbursement are expected from the Centers for […]

2024 Executive Forecast: What 6 Top Home Health Leaders Expect Next Year

Staffing shortages, rate cuts and Medicare Advantage penetration will continue to be trends in the home health market in 2024. Those aren’t new. What is new, however, is how providers plan to combat the issues that stem from those trends. Home health leaders are focused on mitigating margin compression, utilizing more technology, leveraging artificial intelligence, […]

As 2024 Nears, Large Home Health Providers Are Cementing Their MA Strategies

Home health providers’ battle for fair reimbursement from Medicare Advantage (MA) plans will be a “generational battle,” and not one they will win overnight. But, at least for larger home health providers, their strategies in that battle are much more definitive than they were even a few years ago.  Luke James, the president of VitalCaring, […]